BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15978095)

  • 41. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.
    Liang J; Qi Z; Liu W; Wang P; Shi W; Dong W; Ji X; Luo Y; Liu KJ
    Stroke; 2015 May; 46(5):1344-1351. PubMed ID: 25804925
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.
    Su EJ; Cao C; Fredriksson L; Nilsson I; Stefanitsch C; Stevenson TK; Zhao J; Ragsdale M; Sun YY; Yepes M; Kuan CY; Eriksson U; Strickland DK; Lawrence DA; Zhang L
    Acta Neuropathol; 2017 Oct; 134(4):585-604. PubMed ID: 28725968
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dietary vitamin E levels affect outcome of permanent focal cerebral ischemia in rats.
    van der Worp HB; Bär PR; Kappelle LJ; de Wildt DJ
    Stroke; 1998 May; 29(5):1002-5; discussion 1005-6. PubMed ID: 9596250
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epigallocatechin Gallate Extends the Therapeutic Window of Recombinant Tissue Plasminogen Activator Treatment in Ischemic Rats.
    You YP
    J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):990-7. PubMed ID: 26851971
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improved Reperfusion and Vasculoprotection by the Poly(ADP-Ribose)Polymerase Inhibitor PJ34 After Stroke and Thrombolysis in Mice.
    El Amki M; Lerouet D; Garraud M; Teng F; Beray-Berthat V; Coqueran B; Barsacq B; Abbou C; Palmier B; Marchand-Leroux C; Margaill I
    Mol Neurobiol; 2018 Dec; 55(12):9156-9168. PubMed ID: 29651748
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surgery-related thrombosis critically affects the brain infarct volume in mice following transient middle cerebral artery occlusion.
    Lin X; Miao P; Wang J; Yuan F; Guan Y; Tang Y; He X; Wang Y; Yang GY
    PLoS One; 2013; 8(9):e75561. PubMed ID: 24086572
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tacrolimus (FK506) suppresses rt-PA-induced hemorrhagic transformation in a rat thrombotic ischemia stroke model.
    Maeda M; Furuichi Y; Noto T; Matsuoka N; Mutoh S; Yoneda Y
    Brain Res; 2009 Feb; 1254():99-108. PubMed ID: 19101526
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cerebral microvascular obstruction by fibrin is associated with upregulation of PAI-1 acutely after onset of focal embolic ischemia in rats.
    Zhang ZG; Chopp M; Goussev A; Lu D; Morris D; Tsang W; Powers C; Ho KL
    J Neurosci; 1999 Dec; 19(24):10898-907. PubMed ID: 10594071
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice.
    Konstantinides S; Schäfer K; Thinnes T; Loskutoff DJ
    Circulation; 2001 Jan; 103(4):576-83. PubMed ID: 11157725
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thrombolysis and reocclusion in experimental jugular vein and coronary artery thrombosis. Effects of a plasminogen activator inhibitor type 1-neutralizing monoclonal antibody.
    Biemond BJ; Levi M; Coronel R; Janse MJ; ten Cate JW; Pannekoek H
    Circulation; 1995 Feb; 91(4):1175-81. PubMed ID: 7850956
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biological effects of combined inactivation of plasminogen activator and plasminogen activator inhibitor-1 gene function in mice.
    Lijnen HR; Moons L; Beelen V; Carmelie P; Collen D
    Thromb Haemost; 1995 Oct; 74(4):1126-31. PubMed ID: 8560424
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Downstream Microvascular Thrombosis in Cortical Venules Is an Early Response to Proximal Cerebral Arterial Occlusion.
    Desilles JP; Syvannarath V; Di Meglio L; Ducroux C; Boisseau W; Louedec L; Jandrot-Perrus M; Michel JB; Mazighi M; Ho-Tin-Noé B
    J Am Heart Assoc; 2018 Mar; 7(5):. PubMed ID: 29496683
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mild hypothermia reduces tissue plasminogen activator-related hemorrhage and blood brain barrier disruption after experimental stroke.
    Tang XN; Liu L; Koike MA; Yenari MA
    Ther Hypothermia Temp Manag; 2013 Jun; 3(2):74-83. PubMed ID: 23781399
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A combined treatment with tacrolimus (FK506) and recombinant tissue plasminogen activator for thrombotic focal cerebral ischemia in rats: increased neuroprotective efficacy and extended therapeutic time window.
    Maeda M; Furuichi Y; Ueyama N; Moriguchi A; Satoh N; Matsuoka N; Goto T; Yanagihara T
    J Cereb Blood Flow Metab; 2002 Oct; 22(10):1205-11. PubMed ID: 12368659
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Age-dependent spontaneous coronary arterial thrombosis in transgenic mice that express a stable form of human plasminogen activator inhibitor-1.
    Eren M; Painter CA; Atkinson JB; Declerck PJ; Vaughan DE
    Circulation; 2002 Jul; 106(4):491-6. PubMed ID: 12135951
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance.
    Zhu Y; Carmeliet P; Fay WP
    Circulation; 1999 Jun; 99(23):3050-5. PubMed ID: 10368124
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of PAI (Plasminogen Activator Inhibitor)-1 Improves Brain Collateral Perfusion and Injury After Acute Ischemic Stroke in Aged Hypertensive Rats.
    Chan SL; Bishop N; Li Z; Cipolla MJ
    Stroke; 2018 Aug; 49(8):1969-1976. PubMed ID: 29991657
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors.
    Dong W; Li N; Gao D; Zhen H; Zhang X; Li F
    J Vasc Surg; 2008 Sep; 48(3):709-14. PubMed ID: 18572362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circadian rhythms in the efficacy of intravenous alteplase in patients with acute ischemic stroke and middle cerebral artery occlusion.
    Vilas D; Gomis M; Blanco M; Cortés J; Millán M; Pérez de la Ossa N; Dorado L; López-Cancio E; Suñol A; Dávalos A
    Chronobiol Int; 2012 Dec; 29(10):1383-9. PubMed ID: 23130962
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.
    Pfefferkorn T; Rosenberg GA
    Stroke; 2003 Aug; 34(8):2025-30. PubMed ID: 12855824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.